REQUEST A DEMO
Total
USD $0.00
Search more companies

Finoso Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Finoso Pharma Private Limited Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Finoso Pharma Private Limited is an unlisted company, incorporated on 18/08/2009. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24231TG2009PTC064774 and registration number is 064774. The company is a professional, scientific and technical company, it is engaged in scientific research and development.

Legal Address
Sp Biotech Park - Phase-I, Block-I Turkapally, Shameerpet Mandal
Hyderabad; Telangana; Postal Code: 500078

Contact Details: Purchase the Finoso Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Finoso Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Finoso Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Finoso Pharma Private Limited report to view the information.
Incorporation Date:
August 18, 2009
Key Executives
Purchase this report to view the information.
Additional Executive Director
Purchase this report to view the information.
Whole Time Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Finoso Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-10.34%
Total operating revenue
-7.48%
Operating profit (EBIT)
-212.75%
EBITDA
-64.2%
Net Profit (Loss) for the Period
-207.58%
Total assets
17.03%
Total equity
-13.71%
Operating Profit Margin (ROS)
-4.04%
Net Profit Margin
-3.28%
Return on Equity (ROE)
-11.56%
Debt to Equity Ratio
6.47%
Quick Ratio
-0.06%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?